Table 3.

Antibiotic sensitivity and resistance pattern of the CA-MRSA [n=19] and HA-MRSA isolates [n=46].

Antibiotics	NHA#	CPHA#	RHA#	NCA#	CPCA#	RCA#	SHA†[%]	SCA†[%]
Erythromycin[%]	10[83]	2[17]†	12[100]	10[63]	6[37]*	16[100]	7[37]	30[65]*
Clindamycin[%]	7[88]	1[12]†	8[100]	3[60]	2[40]*	5[100]	11[58]	41[89]*
Rifampicin[%]	1[100]	0*	1[100]	0	0*	0	18[95]	46[100]*
Doxycycline[%]	2[100]	0*	2[100]	2[50]	1[50]*	3[100]	17[90]	43[94]*
Vancomycin[%]	3[100]	0*	3[100]	2[50]	2[50]*	4[100]	16[84]	42[91]*
Linezolid[%]	0	0*	0	0	0*	0	19[100]	46[100]*
Teicoplanin[%]	4[100]	0†	4[100]	3[75]	1[25]*	4[100]	15[79]	42[91]*

N- Nasal Swab isolates; CP- Cell phone Swab isolates;

^#R-Number [%] of Resistant MRSA isolates;

-S^†%-Number [%] of sensitive MRSA isolates, CA- Community hospital visitors; HA- Hospital Health-care workers;

^†S - p<0.05, N v/s CP, Chi square test. ;

^*NS - p<0.05, CA v/s HA, Chi square test.^†